News
Iodine, Waystar and Medical software
Digest more
This stock is worth watching for several compelling reasons, including a gamechanging acquisition, ahead of its upcoming earnings.
Waystar to acquire Iodine Software for $1.25 billion to enhance AI tools; deal expected to be accretive to growth and margins by 2027.
Black Book Research identifies Cohere Health, Innovaccer, and Waystar among leading vendors rapidly adapting to new industry ...
Thank you, John, and good afternoon, everyone. It is my pleasure to welcome you to Waystars' Investor conference call. Matt Hawkins, Waystar's Chief Executive Officer; and Steven Oreskovich, Waystar's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results